MedMira Files Patent Application for Next Generation Rapid Test
19-Mar-2008
"Our new test platform provides the user with an even simpler, user-friendly testing procedure than we currently offer in our rapid tests, without sacrificing the high quality and consistent performance that MedMira has built its reputation on," said Dr. Neeraj Vats, Vice President of Technology & Intellectual Property, MedMira Inc. "The new test platform makes it possible to perform a rapid, flow-through test in just two easy steps."
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
List_of_gelechiid_genera:_P
Go to page
RIKEN Systems and Structural Biology Center - Yokohama City, Kanagawa, Japan
Go to page
Dr. Robert Gundel joins Amorfix as Vice President, Research & Development
Go to page
HUBERLAB AG - Reinach AG, Switzerland
Go to page
List_of_limoniid_genera
Go to page
Deutsche Gesellschaft für Qualität e.V. (DGQ) - Frankfurt am Main, Germany
Go to page
Nandrolone
Go to page
Quanterix and STRATEC announce strategic partnership
Go to page
OctoPlus' licensee Biolex presents final Phase IIb results at EASL highlighting tolerability advantages of Locteron in treatment of HCV
Go to page
MediGene appoints Arnd Christ as Chief Financial Officeras Successor to Dr. Thomas Klaue
Go to page
List_of_lycaenid_genera:_J
Go to page